Back
Hansa Biopharma AB Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
39
HNSBF
Hansa Biopharma AB
Last Price:
2.83
Seasonality Move:
-0.32%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.
Hansa Biopharma AB Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Sell |
| 20-day SMA: | 3.45 | Sell |
| 50-day SMA: | 3.35 | Sell |
| 200-day SMA: | 3.06 | Sell |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 3.31 | Sell |
| 50-day EMA: | 3.33 | Sell |
| 200-day EMA: | 3.66 | Sell |
Hansa Biopharma AB Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 8.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.16 - 3.82) | Sell |
| Bollinger Bands (100): | (2.81 - 3.47) | Sell |
Hansa Biopharma AB Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hansa Biopharma AB Stock
Is Hansa Biopharma AB Stock a Buy?
- Hansa Biopharma AB share price is 2.83 while HNSBF 8-day simple moving average is 3.14, which is a Sell signal.
- The stock price of HNSBF is 2.83 while Hansa Biopharma AB 20-day SMA is 3.45, which makes it a Sell.
- Hansa Biopharma AB 50-day simple moving average is 3.35 while HNSBF share price is 2.83, making it a Sell technically.
- HNSBF stock price is 2.83 and Hansa Biopharma AB 200-day simple moving average is 3.06, creating a Sell signal.
HNSBF Technical Analysis vs Fundamental Analysis
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy or a Sell?
-
Hansa Biopharma AB stock is rated a Sell
The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Hansa Biopharma AB Stock Info
Market Cap:
185.68M
Price in USD:
2.83
Share Volume:
0
Hansa Biopharma AB 52-Week Range
52-Week High:
3.65
52-Week Low:
2.26
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Hansa Biopharma AB Share Price Forecast
-
What is the Hansa Biopharma AB stock price today?
The Hansa Biopharma AB stock price is 2.83 USD today. -
Will HNSBF stock go up or go down?
Hansa Biopharma AB> share price is forecast to RISE/FALL based on technical indicators -
Is Hansa Biopharma AB overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hansa Biopharma AB is overvalued.
Is Hansa Biopharma AB Stock a Buy?
- Hansa Biopharma AB share price is 2.83 while HNSBF 8-day exponential moving average is 3.06, which is a Sell signal.
- The stock price of HNSBF is 2.83 while Hansa Biopharma AB 20-day EMA is 3.31, which makes it a Sell.
- Hansa Biopharma AB 50-day exponential moving average is 3.33 while HNSBF share price is 2.83, making it a Sell technically.
- HNSBF stock price is 2.83 and Hansa Biopharma AB 200-day simple moving average is 3.66, creating a Sell signal.
Technical Analysis of Hansa Biopharma AB
Should I short Hansa Biopharma AB stock?
- HNSBF Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Hansa Biopharma AB is a Sell
- Hansa Biopharma AB Relative Strength Index (RSI) is 8.68, which suggest Hansa Biopharma AB is oversold
- The Bollinger Bands (25) for Hansa Biopharma AB is (3.16 - 3.82), which suggest Hansa Biopharma AB is a Sell
- The Bollinger Bands (100) for Hansa Biopharma AB is (2.81 - 3.47), which suggest Hansa Biopharma AB is a Sell
* Hansa Biopharma AB stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.